Aurora kinase inhibitor ENMD-2076 tartrate, Purity ≥98%

Cat. No.: X24-05-ZQ844

Aurora kinase inhibitor ENMD-2076 tartrate, Purity ≥98%

Synonym: 1291074-87-7; ENMD2076; ENMD 2076; Aurora kinase inhibitor

  • CAS Number: 1291074-87-7
  • Compound CID: 66576993
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
ENMD-2076 tartrate, soluble in warmed DMSO and insoluble in water and ethanol, inhibits Aurora kinases, which play crucial roles in cell division by controlling chromosome segregation and cytokinesis. It targets Aurora A, FGFR1, FGFR2, and Flt-4.
Molecular Weight
525.56
Molecular Formula
C25H31N7O6
Targets
Aurora A: 1.86 nM; FGFR1: 92.7 nM; FGFR2: 70.8 nM; Flt-4: 15.9 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 86 mg/mL (163.63 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
ENMD-2076 tartrate is used to explore its effects as a multi-kinase inhibitor, particularly targeting Aurora A and angiogenesis-related kinases.
Storage
Store at -20ºC.

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.